早上三点是什么时辰

　　许兰平，北京大学人民医院，北京大学血液病研究所，主任医师，教授，博士生生导师，副主任。

　　一直从事血液系统疾病的诊治和造血干细胞移植工作，在供者选择、移植合并症处理，尤其在移植治疗再生障碍性贫血和重症感染方面积累了丰富的经验。承担国自然项目2项、曾参加国家科技支撑项目和重大新药创制科技重大专项子课题，发表SCI论文30余篇，参与发表论文SCI或核心期刊文章近300篇。2014和2017年两次名列国家科技进步二等奖获奖人员名单。曾任中华医学会第七、八、九届血液学分会造血干细胞应用学组成员兼秘书，现任海峡两岸医药卫生交流协会第三届理事会常务理事及第二届血液学专委会主任委员，中国研究型医院学会细胞研究与治疗专委会常务委员，中国医师协会血液学分会常务委员、中国造血干细胞捐献者资料库第八届专家委员会委员、北京造血干细胞资料供者库专家，《白血病.淋巴瘤》《中华老年多器官杂志》杂志编委,《中华血液学杂志》通讯编委，《中华内科杂志》审稿人。

　　近三年发表SCI文章：

　　1.Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, Chen YH, Zhang YY, Wang JZ, Wang Y, Yan CH, Sun YQ, Tang FF, Zhang XH, Huang XJ.

　　Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.

　　Bone Marrow Transplant. 2018 Feb;53(2):188-192. doi: 10.1038/bmt.2017.237. Epub 2018 Jan 15

　　2.Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang J, Wu D, Zhou D, Zou P, Liu K, Huang X.

　　The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.J HematolOncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x. Review

　　 3.Cheng Y¹, Xu Z¹, Zhang Y¹, Wu J², Wang F¹, Mo X¹, Chen Y¹, Han W¹, Jia J¹, Wang Y¹, Zhang X¹, Huang X^1,3, Zhang L², Xu L¹

　　First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.clinical transplantation  2018 Feb;32(2). doi: 10.1111/ctr.13179. Epub 2018 Jan 3.

　　4、Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, Liu QF, Wang JM, Wang X, Jiang M, Zhang X, Wu DP, Huang XJ.Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.J HematolOncol. 2017 Jan 21;10(1):25.

　　5、Xu LP, Zhang XH, Wang FR, Mo XD, Han TT, Han W, Chen YH, Zhang YY,  Yan CH, Sun YQ, Zuo SN, Huang XJ.Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia.Bone Marrow Transplant. 2017 Mar;52(3):381-387.

　　6、Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH, Sun ZM, Xia LH, Chen J, Wang HX, Wang C, Li CF, Lai YR, Wang JM, Zhou DB, Chen H, Song YP, Liu T, Liu KY, Huang XJ.

　　A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.Bone Marrow Transplant. 2017 Nov;52(11):1512-1518.

　　7、Chen Y, Huang XJ, Liu KY, Chen H, Chen YH, Zhang XH, Wang Y, Wang FR, Han W, Wang JZ, Yan CH, Xu LP.Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions.Biomark Med. 2017 Feb;11(2):117-124.

　　8、Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, Wang CB, Zhang X, Liu QF, Xia LH, Wang X,Huang XJ. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.

　　Br J Haematol. 2016 Oct;175(2):265-274. doi: 10.1111/bjh.14225.

　　9、Ma YR, Huang XJ, Xu ZL, Liu KY, Chen H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Chen Y, Yan CH, Xu LP. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.Clin Transplant. 2016 Sep;30(9):994-1001. doi: 10.1111/ctr.12779

　　10、Tang FF, Huang XJ, Zhang XH, Chen H, Chen YH, Han W, Chen Y, Wang FR, Wang Y, Wang JZ, Yan CH, Sun YQ, Mo XD, Liu KY, Xu LP.

　　Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.Leuk Res. 2016 Aug;47:8-15. doi: 10.1016/j.leukres.2016.05.005

　　11、Xu ZL, Huang XJ, Liu KY, Chen H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Chen Y, Yan CH, Xu LP.

　　Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia.Pediatr Transplant. 2016 Jun;20(4):572-80. doi: 10.1111/petr.12704.

　　12、Xu LP, Xu ZL, Zhang XH, Chen H, Chen YH, Han W, Chen Y, Wang FR, Wang JZ, Wang Y, Yan CH, Mo XD, Liu KY, Huang XJ.

　　Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Biol Blood Marrow Transplant. 2016 Jun;22(6):1080-6. doi: 10.1016/j.bbmt.2016.03.0126